Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01892605
Other study ID # KMU-IRB-970391
Secondary ID
Status Completed
Phase N/A
First received June 19, 2013
Last updated July 1, 2013
Start date April 2009
Est. completion date December 2011

Study information

Verified date July 2013
Source Kaohsiung Medical University Chung-Ho Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Music has a long history in healing physical and mental illness. The Mozart effect was initially reported by Rauscher, Shaw, and Ky in the journal of "Nature" in the year of 1993. They examined performance on Stanford-Binet spatial tasks immediately following either 10 minutes of listening to Mozart's sonata K.448, silence, or instruction to relax. They found the performance scores were 9 point higher in Mozart-listening group than other two groups. Later, the beneficial influence of Mozart music on parkinson's disease, epilepsy, senile dementia, and attention-deficit/hyperactivity disorder was reported. However, the real neurophysiological mechanism of the influence remains unclear.

Epilepsy is a common disorder in the field of pediatric neurology. Although we had greatly advanced in develop of new anticonvulsant, thirty percent of patients with epilepsy have drug-resistance, which is associated with an increased risk of debilitating psychosocial consequences. In addition, the adverse effects of anticonvulsants are not uncommon. Few reports demonstrated that patients exposed to Mozart's music can significantly decrease in seizure frequencies and interictal epileptiform discharge. However, the case number of these studies was limited and the mechanisms of music therapy on epilepsy were not well known. In our recent studies, Mozart's music indeed decreased the epileptifrom discharge in the patients with epilepsy, particularly in the patients with generalized discharge and central discharge. On the basis of these encouraging results, we will try to investigate the neural mechanisms and clinical applications of music therapy in the following three years.

In the first year of our study, we use animal model to examine the possible mechanism of Mozart's effect. The aim of the second year study is investigation the effect of music on the cortical functions in the epileptic rat model. According to our previous study, Mozart's sonata K.448 was effective in reducing epileptiform discharge. On the basis of previous two-year results, the patients with epilepsy will be enrolled in the third year project to perform an individualized music therapy. In this study, we can provide an alternative therapy in the patients of epilepsy and investigate the possible biological mechanism of music effect.


Description:

Children with first unprovoked seizure were investigated.Patients were randomly classified into treatment and control groups. They did not receive AED after their first unprovoked seizure. The treatment group listened to Mozart K.448 for eight minutes once daily before bedtime for at least six months.All of the patients received follow-up telephone calls monthly. Patients who experienced seizure recurrence were advised to begin AED treatment.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date December 2011
Est. primary completion date October 2011
Accepts healthy volunteers No
Gender Both
Age group N/A to 18 Years
Eligibility Inclusion Criteria:

- children who had epileptiform discharges with first unprovoked seizure

Exclusion Criteria:

- epileptic children without epileptiform discharges

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
music listening
The treatment group listened to Mozart K.448 for eight minutes once daily before bedtime for at least six months.

Locations

Country Name City State
Taiwan Kaohsiung Medical University Hospital Kaohsiung

Sponsors (1)

Lead Sponsor Collaborator
Kaohsiung Medical University Chung-Ho Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

References & Publications (1)

Lin LC, Lee WT, Wu HC, Tsai CL, Wei RC, Mok HK, Weng CF, Lee MW, Yang RC. The long-term effect of listening to Mozart K.448 decreases epileptiform discharges in children with epilepsy. Epilepsy Behav. 2011 Aug;21(4):420-4. doi: 10.1016/j.yebeh.2011.05.015. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary estimate seizure recurrence rate by Kaplan-Meier estimates up to 24 months No
See also
  Status Clinical Trial Phase
Completed NCT00021866 - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy N/A
Completed NCT01417507 - Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery N/A
Completed NCT01123746 - Utility of Laboratory Testing for Children With Seizure in Emergency Department N/A
Completed NCT02926703 - Lactate Compared to Creatine Kinase as Diagnostic Marker in Generalized Epileptic Seizure N/A
Completed NCT01796574 - Ketogenic Diet for Refractory Status Epilepticus N/A
Not yet recruiting NCT01436695 - Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers N/A
Recruiting NCT05746624 - Procedural Motor Memory in Long COVID-19 N/A
Terminated NCT02883712 - Study of Predictors of Response to Anti Epilepsy in Epilepsy
Completed NCT00880204 - Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health Training N/A
Enrolling by invitation NCT02694094 - Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Completed NCT02426047 - Medium Chain Triglycerides as an Adjunct to the Modified Atkins Diet for Women With Catamenial Epilepsy N/A
Completed NCT01834482 - Modified Atkins Diet Plus KetoCal for Adult Epilepsy N/A
Completed NCT01744301 - Acid Suppressing Drug Seizure Epidemiology Study N/A
Completed NCT00946751 - To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions Phase 1
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Terminated NCT01910129 - Neurostimulation to the Vagus Nerve for the Reduction in Frequency of Seizures Associated With Epilepsy N/A
Completed NCT00298532 - OPALS Pediatric Study N/A
Completed NCT01982812 - A Dose-Escalation, Safety and Feasibility Study of Enteral LVT for Seizure Control in Pediatric CM Phase 2
Completed NCT01660672 - Enteral Levetiracetam For Seizure Control In Pediatric Cerebral Malaria Phase 1/Phase 2
Completed NCT00285285 - Point of Care Device Use in the Pediatric Emergency Department N/A